Illumina Sues Premaitha Health Over NIPT IP; Swiss Firm Adopts Premaitha's Iona CE-IVD Test

Mar 16, 2015

|

NEW YORK (GenomeWeb) – Illumina and its wholly-owned subsidiary Verinata Health have filed a patent infringement suit against Premaitha Health over IP relating to non-invasive prenatal testing, the companies said today.

The suit, filed in the High Court of Justice, Chancery Division, Patents Court in the UK, asserts European Patent (UK) 0 994 963 B2 and European Patent (UK) 1 981 995 B1, both relating to the use of cell-free fetal DNA for NIPT.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Corn's Complex Path

A genomic analysis of modern and ancient maize reveals a complicated domestication history, according to Reuters.

This Week in PLOS

In PLOS this week: MYRF variant linked to congenital diaphragmatic hernia, analysis of the "dragon's blood" red resin produced by traditional medicine plants, and more.

Five and Gone

CNBC reports that half of academic researchers leave after about five years.

From Within the Swamp

Researchers have used genetic analysis to confirm a new type of salamander, the New York Times reports.

Main menu